跳至主要内容
临床试验/NCT01155076
NCT01155076已完成不适用

Effects of a Proprietary Ginseng, Cordyceps, and Pomegranate Supplement on Physical and Mental Function in Middle-aged Adults: a Double-blind, Randomized, Placebo-controlled Trial

Pharmanex6 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2010年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pharmanex
入组人数
116
试验地点
6
主要终点
Health-related quality of life

研究概览

简要总结

The purpose of the study is to determine the effects of 8 weeks Vitality Product supplementation on physical and mental function in middle-aged adults

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged 40-70 years
  • Signed Informed Consent
  • BMI between 19 and 30 kg/m2
  • Normotensive, defined as systolic blood pressure 90-140 mmHg and diastolic blood pressure 50-90 mmHg

排除标准

  • Regular dietary supplement use and unwilling to discontinue use at least 1 month prior to enrollment in the study
  • Self-reported chronic condition that may affect subject safety (e.g. diabetes, cardiovascular disease) or significantly impact product effectiveness (e.g. chronic fatigue)
  • Pregnancy/suspected pregnancy, breastfeeding
  • Antihypertensive medication use
  • Allergies to any supplement ingredients
  • Consumption of more than 600mg caffeine from any source per day
  • Consumption of "energy drinks" (e.g. Red Bull, Monster) or any herbal supplement known to affect energy levels
  • Known iron anemia
  • Medically treated for insomnia
  • Medically treated for depression
  • Taking medications known to affect energy, e.g. thyroid medication
  • Tobacco user
  • Planned surgical procedure in next 2 months
  • Participating in another clinical (medical or nutritional) study or likely to enroll in another medical or nutritional study

结局指标

主要结局

Health-related quality of life

时间窗: 8 weeks

次要结局

  • Medical Outcomes Study (MOS) Sexual Function questionnaire(8 weeks)
  • Adverse events(8 weeks)

研究者

发起方
Pharmanex
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验